Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • 2021 Managing Coding - Virtual, September 9-11, 2021

    Includes a Live In-Person Event on 09/09/2021 at 1:00 PM (EDT)

    The AANS Managing Coding & Reimbursement Challenges in Neurosurgery course has been serving the neurosurgical community for more than 20 years. It provides a valuable coding and reimbursement education that is unique in neurosurgery. The course is instructed by a faculty of physician experts and coding consultants who are leaders in code development, revision and valuation of CPT.

    Logged-in course registrants can access information and resources for the Pittsburgh AANS Managing Coding course in the tabs above.

    For an up-to-date listing of available coding courses and resources, please visit www.aans.org/coding.

  • Top 10 Commonly Missed Codes

    At a time when every code counts, review these commonly missed codes.

    image

    Physicians may not be aware of codes they are missing in their practice. This webinar highlights 10 commonly missed codes to empower neurosurgical practices to be confident that their coding is thorough, accurate and that no revenue is left unclaimed.

    Course Date

    July 19, 2021
    7 pm CT

    Faculty

    • John K. Ratliff, MD, FAANS
    • Luis M. Tumialan, MD, FAANS
    • Mark E. Oppenlander, MD, FAANS
    • Clemens M. Schirmer, MD, PhD, FAANS
    • Joseph S. Cheng, MD, MS, FAANS
    • Anand Veeravagu, MD, FAANS
    • Cheerag D. Upadhyaya, MD, FAANS

    Learning Objectives

    Upon completion of this activity participants should be able to:

    • Identify commonly missed codes in routine neurosurgery procedures.
    • Improve revenue cycle by not "leaving money on the table."
    • Describe best practices for coding correctly.

    Pricing

    AANS Member$49
    Non-member$99

    John K. Ratliff, MD, FAANS

    Co-director, AANS Managing Coding Program

    Dr. John Ratliff is Professor and Vice Chair of Neurosurgery, Departmental Quality Officer, and Co-Director of the Spine and Peripheral Nerve Surgery Division. As a spine surgeon, he treats a diverse array of degenerative spinal conditions. He has a specific research emphasis on quality improvement, decreasing complications in spine surgery, and improving surgical treatment of intramedullary spinal cord tumors.

    Dr. Ratliff has served on the Executive Committee of the Congress of Neurological Surgeons and the Joint Section of Disorders of Spine and Peripheral Nerves, is Treasurer for the Council of State Neurosurgical Societies, and is on the Board of Directors of Neuropoint Alliance. He is immediate past-chairman of the joint AANS/CNS Neurosurgery Quality Council.

    Luis Manuel Tumialán, MD, FAANS

    Co-director, AANS Managing Coding Program

    LUIS MANUEL TUMIALÁN, MD, FAANS, Co-director

    Dr. Tumialán received his medical degree from Georgetown University School of Medicine. He completed an internship at the Naval Medical Center in San Diego and completed his residency training at Emory University School of Medicine in Atlanta. He spent an additional two years at the Naval Medical Center in San Diego upon the completion of his residency as a staff neurosurgeon before joining the Barrow Neurological Institute (BNI) in Phoenix. Dr. Tumialán specializes in minimally invasive spine surgery and cervical and lumbar arthroplasty. He is currently a member of the AANS/CNS Coding and Reimbursement Committee.


    Mark Oppenlander, MD, FAANS

    Dr. Mark Oppenlander is a neurosurgeon and clinical assistant professor at the University of Michigan department of neurosurgery. He specializes in complex spinal operations, including spinal deformity, scoliosis, spinal tumors, thoracic disc disease, craniovertebral junction surgery, robotics in neurosurgery and more.

    Dr. Oppenlander attended the University of Michigan, where he graduated with Highest Distinction and a Bachelor of Science in cellular and molecular biology. He went on to earn his Doctor of Medicine at the University of Michigan Medical School. In 2008, Dr. Oppenlander moved to Phoenix, where he completed a seven-year residency training program in neurological surgery at the Barrow Neurological Institute (BNI). He also spent time at Thomas Jefferson University in Philadelphia, where he obtained fellowship training in Complex Spine Surgery. In addition, Dr. Oppenlander was awarded the Royal College of Surgeons of Edinburgh Overseas Training Sponsorship, providing opportunity to travel to London for further fellowship training in Complex Spine Surgery and Spinal Oncology at the National Hospital for Neurology and Neurosurgery at Queen Square.

    Dr. Oppenlander has published numerous peer-reviewed articles, book chapters and abstracts, as well as participated in conferences at the state, national and international level with multiple invited presentations. He acts as a Neurotrauma Consultant for the National Football League. Additionally, Dr. Oppenlander is an active member of the AANS, the CNS, the North American Spine Society (NASS) and the AANS/CNS section on Disorders of the Spine and Peripheral Nerves.

    Clemens M. Schirmer, MD, PhD, FAANS

    Neurosurgeon

    Dr. Schirmer earned his medical degree and a doctorate in medical research from Ludwig-Maximilians University in Munich, Germany and at Harvard Medical School under the auspices of the Harvard Munich Alliance for Medical Education. He then completed his residency in neurosurgery and fellowship in interventional neuroradiology at the Tufts Medical Center program in Boston. ABNS board certified in neurological surgery and holding CAST certificates both in neuroendovascular surgery and neurocritical care, he currently serves as vice chair in the department of neurosurgery and is professor of neurosurgery and neuroscience in the unmodified research track at the Geisinger Commonwealth School of Medicine. Dr. Schirmer also serves as the system director of the Geisinger Comprehensive Stroke Centers and System Director of Cerebrovascular and Endovascular Neurosurgery, specializing in the treatment of stroke and related vascular disorders of the brain and spine using surgery, endovascular and radiation modalities. He is the program director of the Geisinger Neurosurgery residency training program and the CAST Neuroendovascular Fellowship program.

    His research interests focus on the quality metrics, variation of care, shared decision making and patient centered outcomes, genomics and biomarkers of stroke, machine learning and data analytics. He serves as principal investigator of several clinical trials in the stroke arena aiming to bringing novel and innovative therapies to the market and creating premier Geisinger initiatives.

    He serves as chair-elect of the AANS/CNS Cerebrovascular Section and the executive committee of the Congress of Neurological Surgeons where he is co-chair of the International Division and on the board of the CNS foundation, chair of the public relations and communications subcommittee of the AANS/CNS Washington Committee and Advisor to the AMA RBRVS RUC Committee. He has been appointed to MEDCAC and appointed to the Premier Group Purchasing Organization Member Cardiovascular Advisory Committee and multiple CMS/Acumen Cost- and Medicare Spending per Beneficiary- Measure Development Panels.

    Anand Veeravagu, MD

    Dr. Anand Veeravagu is assistant professor of neurosurgery and assistant professor of orthopedic surgery, by courtesy, and director of minimally invasive spine surgery at Stanford. Dr. Veeravagu is focused on advancing minimally invasive surgical techniques for diseases of the spine and cares for patients with a wide range of spinal disorders. Dr. Veeravagu graduated from the Johns Hopkins University Biomedical Engineering program with a focus on spinal cord injury and regeneration. Committed to medical device development, neuroregeneration, and non-invasive imaging he accepted a position to complete his MD at the Stanford University School of Medicine.

    After completion of his neurosurgical residency, Dr. Veeravagu was awarded the prestigious Neurosurgical Research and Education Foundation Post-Residency Clinical Fellowship Grant and completed his fellowship training in minimally invasive and complex deformity spine at Stanford University with both neurosurgical and orthopaedic training. He also completed a clinical scholar rotation at the University of Miami Miller School of Medicine, focused on endoscopic and robotic spine surgery.

    Dr. Veeravagu’s research efforts are focused on the utilization of large national databases to assess cost, quality and effectiveness of various treatment algorithms as well as predictive analytics. Dr. Veeravagu is also an author and writes about current events, health policy, and public health-related topics for the San Francisco Chronicle, The Daily Beast, The BBC and the Huffington Post.

    Joseph Cheng, MD, MS, FAANS

    Chair, Department of Neurosurgery, University of Cincinnati

    Cheerag D. Upadhyaya, MD, FAANS

    Dr. Cheerag D. Upadhyaya, is a fellowship-trained neurosurgeon specializing in complex and minimally invasive spine surgery. He is director of the spine program and surgical director for the Saint Luke’s Marion Bloch Neuroscience Institute. Prior to joining Saint Luke’s in May 2014, he had practiced at Kadlac Neuroscience Center in Richland, Washington.

    After earning his medical degree from the University of Florida, Dr. Upadhyaya completed his neurosurgical residency at the University of Michigan. While there, he earned a master’s degree in clinical research from the University of Michigan.

    Dr. Upadhyaya completed his fellowship in complex and minimally invasive spine surgery at the University of California San Francisco. His clinical research has appeared in numerous journals, books, videos, and at industry conferences.

    Dr. Upadhyaya is a Clinical Associate Professor at the University of Missouri–Kansas City School of Medicine.

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

    NameDisclosureType of Relationship
    *John Kevin Ratliff, MD, FAANSStryker Spine

    Medtronic, NuVasive

    Consultant

    Consultant Honorarium

     

    *Luis Manuel Tumialán, MD, FAANS

     

     Medtronic, LessRay               

     

    Consultant Honorarium

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


  • Neurosurgical Focus: Video, July 2021: Pineal region tumors Volume 5: Issue 1

    Includes Credits

    .25 CME | AANS Member: Free| Non-member: $79

    Neurosurgical Focus: Video: This quarterly open-access, online-only journal presents high-definition videos of neurosurgery-related procedures, creating a unique educational experience that makes viewers feel present in the operating room. 

    Registration Fee

    AANS MembersFree
    Non-members$79

    CME Credit

    Earn up to .25 CME credits by participating.

    Learning Objectives

    Upon completion of this CME activity, participants should be able to:

    • The participant will develop a better understanding of the surgical indication for resection of pineal region tumors.
    • The participant will develop a greater knowledge of the technical nuances for pineal region surgery.
    • The participant will learn about innovative methods to treat pineal region tumors.
    • The participant will gain a greater appreciation of complication management during pineal region surgery. 

    Disclosure Information

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Those who have reported they do not have any relationships with commercial interests:

    Dr. Gustavo Pradilla 

    Dr. Mustafa Baskaya

    Disclaimer

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

    Accreditation Designation

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this internet enduring material for a maximum of  .25 AMA PRA Category 1 CreditTM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

    Term of approval is for three years, beginning from 07/01/2021 to 7/1/2024.

    Upon successful completion of the CME test, credit will automatically be reflected in your member record. Non-members must print a certificate and retain a copy for your CME records. 

    Copyright © 2021 American Association of Neurological Surgeons

  • NSF July 2021: Neurosurgical management of stroke, organization of stroke management and AI (artificial intelligence) applications Volume 51, issue 1

    Includes Credits

    3 CME | AANS Member: Free| Non-member: $79

    Neurosurgical Focus covers a different topic in-depth each month. Enhanced by color images and video clips, each peer-reviewed issue constitutes a state-of-the-art “textbook chapter” in the field of neurosurgery. 

    While Neurosurgical Focus is open-access and has been free to the public since 1996, claiming CME credit is free only for AANS members. Each monthly issue offers 3 credits - earn up to 36 CME annually.

    Registration Fee

    AANS MembersFree
    Non-members$79

    CME Credit

    Earn up to 3 CME credits by participating.

    Learning Objectives

    Upon completion of this CME activity, participants should be able to:

    • Develop a better understanding of neurosurgical management of stroke.
    • Develop a greater knowledge of organization of stroke management.
    • Learn about the cutting-edge applications for management of stroke.
    • Gain a greater understanding and appreciation for future technologies for stroke management.  

    Disclosure Information

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Those who have reported they do not have any relationships with commercial interests:

    Victor Yang 

    Adnan Siddiqui

    Disclaimer

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

    Accreditation Designation

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this internet enduring material for a maximum of 3.00 AMA PRA Category 1 CreditTM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

    Term of approval is for three years, beginning from 07/01/2021 to 07/1/2024.

    Upon successful completion of the CME test, credit will automatically be reflected in your member record. Non-members must print a certificate and retain a copy for your CME records. 

    Copyright © 2021 American Association of Neurological Surgeons

  • Front Row: Cerebrovascular

    Includes Credits

    This Front Row series provides access to respected key opinion leaders in cerebrovascular neurosurgery. Registrants can submit cases to be addressed during live discussions and gain insight on complex and nuanced cases

    image

    Experts share valuable and relevant information in this series on cerebrovascular neurosurgery. Registrants are able to submit cases to be addressed during live discussions and gain insight on complex and nuanced cases. Take a front row seat as neurosurgical leaders guide you through the following webinars:

    Schedule

    May 10, 2021
    6 pm CT
    Radial First Eric C. Peterson, MD, FAANS;
    Josh Osbun, MD, FAANS;
    Michael Levitt, MD, FAANS
    May 27, 2021
    6pm CT
    Cerebral Bypass Surgery: A Nexus of Maths, Physics, Judgement, Skills and Innovation Jacques Morcos, MD, FAANS
    The Evolution of Bypass Surgery for the Treatment of Cerebral Aneurysms Michael Lawton, MD, FAANS
    The Role of Flow Measurements in Bypass Surgery for Ischemic Disease Fady Charbel, MD, FAANS
    June 9, 2021
    7 pm CT
    Surgical Treatment of Hemorrhagic Stroke - Where Do We Stand? Gustavo Pradilla, MD, FAANS
    An Update on the Endovascular Treatment of Ischemic Stroke J Mocco, MD, FAANS
    July 7, 2021
    6 pm CT
    The Evidence behind the Treatment of dAVF Gregory Zipfel, MD, FAANS
    Dural Arteriovenous Fistulas Made Ridiculously Simple Bradley Gross, MD, FAANS

    Pricing

    AANS Member$129
    Non-member$199


    Attendees will be able to submit cases and questions prior to the webinar by sending a message to epm@aans.org. These questions will be answered live during the webinar. 

    The recordings will be available to those who purchase the live event.

    CME Credits

    The AANS designates this other activity ( live internet activity and enduring material)  for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Explain transradial diagnostic cerebral angiography.
    • Identify the three phases in diagnostic angiograph.

    Gregory J. Zipfel, MD

    Ralph G. Dacey Distinguished Professor of Neurological Surgery Chair, Department of Neurological Surgery

    Neurosurgeon-in-Chief, Barnes-Jewish Hospital

    Bradley Gross, MD

    Director, Endovascular Surgery Assistant Professor Neurological Surgery

    University of Pittsburg Medical Center

    Jacques J Morcos, MD, FRCS, FAANS

    Brain and Tumor Neurosurgery, Endovascular Neurosurgery, Neurosurgery, Neurosurgical Oncology

    University of Miami Health Systems

    Michael Lawton, MD

    Professor & Chairman, Department of Neurological Surgery President & CEO, Barrow Neurological Institute Chief of Vascular & Skull Base Neurosurgery The Robert F. Spetzler Endowed Chair in Neurosciences

    Barrow Neurological Institute

    Fady T. Charbel, MD, FAANS, FACS

    Head and Program Director Department of Neurosurgery Richard L. and Gertrude W. Fruin Professor

    University of Illinois at Chicago

    Gustavo Pradilla, MD

    Pediatric Neurosurgery

    Emory University Hospital

    J Mocco, MD

    PROFESSOR | Neurosurgery

    Mount Sinai

    Georgios Zenonos, MD

    Assistant Professor Neurological Surgery

    UPMC

  • Front Row: Skull Base

    Includes Credits

    Get access to respected key neurosurgery leaders in skull base as they share relevant and timely information.

    image

    Take a front row seat as the experts share valuable and relevant information in this series on skull base neurosurgery. 

    Registrants can submit cases to be addressed during live discussions and gain insight on complex and nuanced cases. This series includes the following webinars:

    Schedule

    April 22, 2021 New Approaches in Skull Base Surgery Paul Gardner, MD, FAANS
    The Learning Curve in Endoscopic Endonasal Surgery: Milestones from a Novice to a Master Surgeon Theodore H. Schwartz, MD, FAANS
    April 26, 2021 Cutting Edge Anatomical Concepts in Pituitary Surgery Juan Fernandez-Miranda, MD, IFAANS
    Modern Reconstructive Techniques in Pituitary Surgery and Beyond James Evans, MD, FAANS
    June 2, 2021 Molecular and Translational Advances in Skull Base Tumors Ian Dunn, MD, FAANS
    The Path to Successful Career as a Surgeon-scientist. The Ins and Outs, Ups and Downs of Doing it Right Both Ways Albert Kim, MD, PhD, FAANS
    July 26, 2021
    6 pm CT
    Keyhole Approaches for Skull Base Surgery Gabrielle Zada, MD, FAANS
    Endoscopic versus Lateral Approaches: When and Why? Daniel Prevedello, MD

    Pricing


    AANS Member$129
    Non-member$199


    Attendees will be able to submit cases and questions prior to the webinar by sending a message to epm@aans.org. These questions will be answered live during the webinar. 

    The recordings will be available to those who purchase the live event.

    CME Credits

    The AANS designates this other activity ( live internet activity and enduring material)  for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Recognize how one learns and improves in a complex, high risk specialty such as neurosurgery.
    • Evaluate the lateral orbitotomy approach for lesions involving the middle fossa.
    • Identify the steps in transpterygoid approach.
    • Describe some standard repair techniques utilized for endoscopic pituitary surgery.

    Ian F. Dunn, MD

    Harry Wilkins, MD Professor and Chair Department of Neurosurgery

    University of Oklahoma School of Medicine/OU Health

    Albert H. Kim, MD, PhD

    Director, Brain Tumor Center Surgical Director, Pituitary Center Professor of Neurological Surgery, Genetics, Neurology, and Developmental Biology Department of Neurological Surgery

    Washington University School of Medicine Siteman Cancer Center

    Gabriel Zada, MD, MS, FAANS, FACS

    Professor of Neurological Surgery, Otolaryngology, and Internal Medicine Director, USC Brain Tumor Center Associate Residency Program Director

    USC Keck School of Medicine | University of Southern California

    Daniel Prevedello, MD

    Vice Chair for Academic Affairs ProfessorDirector, Minimally Invasive Cranial Surgery Program College of Medicine Department of Neurological Surgery

    The Ohio State University Wexner Medical Center

    Georgios Zenonos, MD

    Assistant Professor Neurological Surgery

    UPMC

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

    Name Company/Relationship
    Paul A. Gardner, MD, FAANS SPIWay - Stock Shareholder (purchased direct, i.e. not through Mutual Fund, retirement package, etc.) Self Lazic - Consultant Fees- Self Zeiss - Speaker's Bureau -self
    Name  Company/Relationship
    Juan Carlos Fernandez-Miranda, MD, FAANS KLS Martin Other Financial Support
    Varun R. Kshettry, MD, FAANS Integra Consultant Fees   Stryker Consultant Fees
    James J. Evans, MD, FAANS Mizuho: Surgical instrument development Other Financial Support

     



    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this other activity ( live internet activity and enduring material)  for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


  • NSF: June 2021: Biologics and spinal fusion Volume 50, issue 6

    Includes Credits

    3 CME | AANS Member: Free| Non-member: $79

    Neurosurgical Focus covers a different topic in-depth each month. Enhanced by color images and video clips, each peer-reviewed issue constitutes a state-of-the-art “textbook chapter” in the field of neurosurgery. 

    While Neurosurgical Focus is open-access and has been free to the public since 1996, claiming CME credit is free only for AANS members. Each monthly issue offers 3 credits - earn up to 36 CME annually.

    Registration Fee

    AANS MembersFree
    Non-members$79

    CME Credit

    Earn up to 3 CME credits by participating.

    Learning Objectives

    Upon completion of this CME activity, participants should be able to:

    • The participant will develop a better understanding of the biological cascade involved with spinal fusion.
    • The participant will develop a greater knowledge of the mechanisms that can augment spinal fusion.
    • The participant will learn about the various types of biologics used for spinal fusion and additional agents expected to be available in the near future.
    • The participant will gain a greater understanding and appreciation of the advantages and disadvantages as well as cost profile of spinal fusion biologics.

    Disclosure Information

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Those who have reported they do not have any relationships with commercial interests:

    Mathieu Bannwarth

    Eric Potts

    Rajiv Saigal

    Disclaimer

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

    Accreditation Designation

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this internet enduring material for a maximum of 3.00 AMA PRA Category 1 CreditTM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

    Term of approval is for three years, beginning from 06/01/2021 to 06/1/2024.

    Upon successful completion of the CME test, credit will automatically be reflected in your member record. Non-members must print a certificate and retain a copy for your CME records. 

    Copyright © 2021 American Association of Neurological Surgeons

  • Front Row: Tumor/Radiosurgery

    Includes Credits

    This Front Row series will provide ‘front row’ access to respected key opinion leaders in a Tumor and Radiosurgery. Registrants can submit cases to be addressed during live discussions and gain insight on complex and nuanced cases.

    image

    Take a front row seat as the experts share valuable and relevant information in this series on tumor and radiosurgery. 

    Registrants can submit cases to be addressed during live discussions and gain insight on complex and nuanced cases. The Front Row Series includes the following webinars:

    Schedule

    May 3, 2021
    6 pm CT
    An Update on LITT for Deep Seated Tumors Michael Ivan, MD, FAANS
    State of Immunotherapy for GBM Michael Lim, MD, FAANS
    May 17, 7 pm CT Radiosurgery for Brain Metastases A Game Changer for Neurosurgeons and Oncologists L. Dade Lunsford, MD, FAANS
    Radiosurgery for Arteriovenous Malformations and Trigeminal Neuralgia Jason Sheehan, MD, PhD, FAANS
    May 24, 5 pm CT Minimally Invasive Parafascicular Surgery for Deep-Seated Brain Tumors Kaisorn Chaichana, MD, FAANS
    5-ALA Fluorescence-Guided Surgery for High-Grade Gliomas Constantinos Hadjipanayis, MD, PhD, FAANS

    Pricing

    AANS Member$99
    Non-member$179


    Attendees will be able to submit cases and questions prior to the webinar by sending a message to epm@aans.org. These questions will be answered live during the webinar. 

    The recordings will be available to those who purchase the live event.

    CME Credits

    The AANS designates this other activity ( live internet activity and enduring material) for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Describe the Standard of Care for High-Grade Gliomas and Limitations of Surgical Resection
    • Explain 5-ALA Fluorescence-Guided Surgery
    • Describe Traditional Surgical Approaches to Subcortical Brain Tumors
    • Identify MIPS for Deep-Seated High Grade Gliomas

    L. Dade Lunsford, MD

    Lars Leksell Professor and Distinguished Professor Director Neurological Surgery Center for Image-Guided Neurosurgery Residency Training Program

    University of Pittsburgh Medical Center

    Jason Sheehan, MD, PhD

    Departments of Neurological Surgery and Radiation Oncology

    University of Virginia

    Kaisorn Chaichana, MD, FACS, FAANS

    Associate Professor of Neurosurgery Vice Chair of Education Neurosurgery Residency Program Director Director of Brain Tumor Surgery Director of Skull Base and Minimally Invasive Cranial Surgery

    Mayo Clinic

    Constantinos (Costas) G. Hadjipanayis, M.D., Ph.D.

    Professor of Neurosurgery and Oncological Sciences Chair of Neurosurgery, Mount Sinai Union Square/Beth Israel Director of Neurosurgical Oncology, Mount Sinai Health System Director, Brain Tumor Nanotechnology Laboratory, Tisch Cancer Institute

    Icahn School of Medicine at Mount Sinai

    Georgios Zenonos, MD

    Assistant Professor Neurological Surgery

    UPMC

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

    Name

    Company/Relationship

     

    Michael Ivan, MD

    Medtronic

    Grants/Research Support

     

    NX development

    Consultant Fees

     

    Magicleap

    Grants/Research Support

    Michael Lim, MD

    Arbor, BMS, Accuray, Tocagen, Biohaven, Kyrin-Kyowa, Biohaven

    Grants/Research Support

     

    Tocagen, VBI, InCephalo Therapeutics, Pyramid Bio, Merck, BMS, Insightec, Biohaven, Sanianoia, Hemispherian, Black Diamond Therapeutics

    Consultant Fees

     

    Egret Therapeutics

    Board, Trustee, Officer, Leadership position that could affect an entities' finances

    Dale Lunsford, MD

    Elekta

    Stock Shareholder (purchased direct, i.e. not through Mutual Fund, retirement package, etc.)

     

    Insightec DSMB

    Consultant Fees

     

    International Radiosurgery Research Foundation

    Board, Trustee, Officer, Leadership position specifically with a neurosurgical or medical-related associated, non-profit or similar entity

     

    Teladoc

    Expert Medical Opinion Services Income

    Constantinos G. Hadjipanayis, MD, PhD, FAANS

    Synaptive Inc.

    Consultant Fees

                  

    NX Development Corp

    Consultant Fees

     

    Stryker

    Other Financial Support

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this other activity ( live internet activity and enduring material) for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

    .



  • 2021 Evaluation & Management (E/M) Code Changes White Paper

    This free download addresses evaluation and management code changes.

    image

    New E/M definitions for outpatient clinic visits for 2021 include two ways to code outpatient services in the new system, based either on time or complexity of medical decision making.

    Written by John K. Ratliff, MD, FAANS, this free, downloadable white paper addresses recent code changes relevant to neurosurgery.

    About the AANS 

    The American Association of Neurological Surgeons, a scientific and educational association founded in 1931, is committed to supporting neurosurgeons and their practices through educational resources, patient information and political advocacy.

    Pricing

    AANS MemberFREE
    Non-memberFREE

    John K. Ratliff, MD, FAANS

    Chair, AANS/CNS Washington Committee Professor of Neurosurgery Professor of Orthopedic Surgery (by courtesy) Vice Chair, Operations Department Quality Officer Associate Program Director Co-Director, Division of Spine and Peripheral Nerve Surgery

    Department of Neurosurgery Stanford University Medical Center

  • NSF MAY 2021: Treatment of spinal cord and spinal axial tumors Volume 50, issue 5

    Includes Credits

    3 CME | AANS Member: Free| Non-member: $79

    Neurosurgical Focus covers a different topic in-depth each month. Enhanced by color images and video clips, each peer-reviewed issue constitutes a state-of-the-art “textbook chapter” in the field of neurosurgery. 

    While Neurosurgical Focus is open-access and has been free to the public since 1996, claiming CME credit is free only for AANS members. Each monthly issue offers 3 credits - earn up to 36 CME annually.

    Registration Fee

    AANS MembersFree
    Non-members$79

    CME Credit

    Earn up to 3 CME credits by participating.

    Learning Objectives

    Upon completion of this CME activity, participants should be able to:

    • The participant will develop a better understanding of the prevalence of spinal cord tumors.
    • The participant will develop a greater knowledge of the types and natural history of spinal cord tumors.
    • The participant will learn about the surgical approaches used in contemporary management of spinal cord tumors.
    • The participant will gain a greater understanding and appreciation of the post-operative management including complications of spinal cord surgical treatment.

    Disclosure Information

    The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

    The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

    It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

    All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

    Those who have reported they do not have any relationships with commercial interests:

    Lennart Viezens

    Ori Barzilai

    Michael Galgano

    Disclaimer

    The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

    Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

    Accreditation Designation

    The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The AANS designates this internet enduring material for a maximum of 3.00 AMA PRA Category 1 CreditTM.

    Physicians should claim only credit commensurate with the extent of their participation in the activity.

    Term of approval is for three years, beginning from 05/01/2021 to 05/1/2024.

    Upon successful completion of the CME test, credit will automatically be reflected in your member record. Non-members must print a certificate and retain a copy for your CME records. 

    Copyright © 2021 American Association of Neurological Surgeons